2:I[6146,[],""]
3:I[4411,[],""]
4:"$Sreact.suspense"
5:I[7256,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"KeyboardNavigation"]
6:I[5407,["863","static/chunks/863-822c2cde35e02348.js","185","static/chunks/app/layout-fb78cfc571d4c3d6.js"],"SlideNavigation"]
0:["DkpgZd6XOJjDaY981EGFp",[[["",{"children":["pages",{"children":["10",{"children":["__PAGE__",{}]}]}]},"$undefined","$undefined",true],["",{"children":["pages",{"children":["10",{"children":["__PAGE__",{},[["$L1",["$","div",null,{"className":"relative overflow-hidden w-[1920px] h-[1080px] bg-gradient-to-br from-slate-900 to-slate-700 text-white","children":["$","div",null,{"className":"flex flex-col w-full h-full","children":[["$","div",null,{"className":"flex-none bg-slate-800/90 p-6 flex items-center gap-4","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":48,"height":48,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-award text-orange-400","children":[["$","path","1yiouv",{"d":"m15.477 12.89 1.515 8.526a.5.5 0 0 1-.81.47l-3.58-2.687a1 1 0 0 0-1.197 0l-3.586 2.686a.5.5 0 0 1-.81-.469l1.514-8.526"}],["$","circle","1vp47v",{"cx":"12","cy":"8","r":"6"}],"$undefined"]}],["$","h1",null,{"className":"text-6xl font-bold text-white","children":"Investment Thesis & Conclusion"}]]}],["$","div",null,{"className":"flex-1 min-h-0 grid grid-cols-[3fr_2fr] gap-6 p-8","children":[["$","div",null,{"className":"flex flex-col gap-4","children":[["$","h2",null,{"className":"text-4xl font-bold text-white","children":"Investment Thesis"}],["$","div",null,{"className":"bg-slate-800/90 p-4 rounded-lg border-l-4 border-blue-400","children":["$","p",null,{"className":"text-2xl bg-gradient-to-r from-blue-400 to-purple-400 bg-clip-text text-transparent font-bold","children":"Unloxcyt offers a compelling opportunity in the cSCC market with a first-in-class mechanism, backed by Sun Pharma's global infrastructure."}]}],["$","h3",null,{"className":"text-4xl font-bold text-white mt-2","children":"Why Unloxcyt Succeeds"}],["$","div",null,{"className":"space-y-4","children":[["$","div",null,{"className":"flex items-start gap-4 bg-slate-800/90 p-3 rounded-lg","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":28,"height":28,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-target text-blue-400 mt-1 flex-shrink-0","children":[["$","circle","1mglay",{"cx":"12","cy":"12","r":"10"}],["$","circle","1vlfrh",{"cx":"12","cy":"12","r":"6"}],["$","circle","1c9p78",{"cx":"12","cy":"12","r":"2"}],"$undefined"]}],["$","div",null,{"children":[["$","h4",null,{"className":"text-2xl font-bold text-white","children":"Market Validation"}],["$","p",null,{"className":"text-xl text-gray-300","children":"FDA approved; $1B+ U.S. market with strong annual growth."}]]}]]}],["$","div",null,{"className":"flex items-start gap-4 bg-slate-800/90 p-3 rounded-lg","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":28,"height":28,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-zap text-purple-400 mt-1 flex-shrink-0","children":[["$","path","1xq2db",{"d":"M4 14a1 1 0 0 1-.78-1.63l9.9-10.2a.5.5 0 0 1 .86.46l-1.92 6.02A1 1 0 0 0 13 10h7a1 1 0 0 1 .78 1.63l-9.9 10.2a.5.5 0 0 1-.86-.46l1.92-6.02A1 1 0 0 0 11 14z"}],"$undefined"]}],["$","div",null,{"children":[["$","h4",null,{"className":"text-2xl font-bold text-white","children":"Differentiation Advantage"}],["$","p",null,{"className":"text-xl text-gray-300","children":"First-and-only PD-L1 inhibitor for cSCC with a unique ADCC mechanism."}]]}]]}],["$","div",null,{"className":"flex items-start gap-4 bg-slate-800/90 p-3 rounded-lg","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":28,"height":28,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-trending-up text-green-400 mt-1 flex-shrink-0","children":[["$","polyline","126l90",{"points":"22 7 13.5 15.5 8.5 10.5 2 17"}],["$","polyline","kwv8wd",{"points":"16 7 22 7 22 13"}],"$undefined"]}],["$","div",null,{"children":[["$","h4",null,{"className":"text-2xl font-bold text-white","children":"Revenue Potential"}],["$","p",null,{"className":"text-xl text-gray-300","children":"Peak sales projection of $1.2-1.4B with 30-35% market share capture."}]]}]]}],["$","div",null,{"className":"flex items-start gap-4 bg-slate-800/90 p-3 rounded-lg","children":[["$","svg",null,{"xmlns":"http://www.w3.org/2000/svg","width":28,"height":28,"viewBox":"0 0 24 24","fill":"none","stroke":"currentColor","strokeWidth":2,"strokeLinecap":"round","strokeLinejoin":"round","className":"lucide lucide-globe text-blue-400 mt-1 flex-shrink-0","children":[["$","circle","1mglay",{"cx":"12","cy":"12","r":"10"}],["$","path","13o1zl",{"d":"M12 2a14.5 14.5 0 0 0 0 20 14.5 14.5 0 0 0 0-20"}],["$","path","9i4pu4",{"d":"M2 12h20"}],"$undefined"]}],["$","div",null,{"children":[["$","h4",null,{"className":"text-2xl font-bold text-white","children":"Global Infrastructure"}],["$","p",null,{"className":"text-xl text-gray-300","children":"Sun Pharma provides commercial capabilities and global expansion pathways."}]]}]]}]]}]]}],["$","div",null,{"className":"flex flex-col gap-4","children":[["$","div",null,{"className":"bg-slate-800/90 p-4 rounded-lg","children":[["$","h3",null,{"className":"text-3xl font-bold text-orange-400 mb-3","children":"Valuation Snapshot"}],["$","div",null,{"className":"space-y-2","children":[["$","div",null,{"className":"flex justify-between items-center","children":[["$","p",null,{"className":"text-xl text-gray-300","children":"Acquisition Value"}],["$","p",null,{"className":"text-2xl font-bold text-green-400","children":"$$416M"}]]}],["$","div",null,{"className":"flex justify-between items-center","children":[["$","p",null,{"className":"text-xl text-gray-300","children":"Peak Sales (Base)"}],["$","p",null,{"className":"text-2xl font-bold text-green-400","children":"$$1.2-1.4B"}]]}],["$","div",null,{"className":"flex justify-between items-center","children":[["$","p",null,{"className":"text-xl text-gray-300","children":"Risk-Adjusted NPV"}],["$","p",null,{"className":"text-2xl font-bold text-green-400","children":"$$3.0-5.5B"}]]}],["$","div",null,{"className":"flex justify-between items-center","children":[["$","p",null,{"className":"text-xl text-gray-300","children":"Time to Peak"}],["$","p",null,{"className":"text-2xl font-bold text-green-400","children":"4-6 years"}]]}]]}]]}],["$","div",null,{"className":"bg-slate-800/90 p-4 rounded-lg","children":[["$","h3",null,{"className":"text-3xl font-bold text-white mb-3","children":"Risk-Reward Profile"}],["$","div",null,{"className":"space-y-2","children":[["$","div",null,{"className":"flex justify-between items-center","children":[["$","p",null,{"className":"text-xl text-gray-300","children":"Risk Level"}],["$","p",null,{"className":"text-xl font-bold text-orange-400","children":"Moderate-High"}]]}],["$","div",null,{"className":"flex justify-between items-center","children":[["$","p",null,{"className":"text-xl text-gray-300","children":"Reward Potential"}],["$","p",null,{"className":"text-xl font-bold text-green-400","children":"Substantial"}]]}],["$","p",null,{"className":"text-base text-gray-400 pt-1","children":"Key Risks: Competition, market capture execution"}],["$","p",null,{"className":"text-base text-gray-400","children":"Key Rewards: Billion-dollar revenue, global expansion"}]]}]]}],["$","div",null,{"className":"bg-gradient-to-r from-purple-600 to-purple-500 p-4 rounded-lg flex-grow flex flex-col","children":[["$","h3",null,{"className":"text-3xl font-bold text-white mb-2","children":"Strategic Imperative"}],["$","p",null,{"className":"text-xl text-white mb-3","children":"Execute flawless commercialization to capture market share and build a foundation for global growth."}],["$","div",null,{"className":"space-y-1 mt-auto","children":[["$","p",null,{"className":"text-base text-purple-100","children":"• Immediate: U.S. market establishment"}],["$","p",null,{"className":"text-base text-purple-100","children":"• Near-term: European approvals"}],["$","p",null,{"className":"text-base text-purple-100","children":"• Long-term: Asia-Pacific expansion"}]]}]]}]]}]]}],["$","div",null,{"className":"flex-none p-4 flex justify-between items-center bg-slate-800/50","children":[["$","p",null,{"className":"text-base text-gray-400","children":"For inquiries: strategic.intelligence@pharma.com"}],["$","p",null,{"className":"text-lg text-gray-300 font-bold","children":"Unloxcyt: Transforming Advanced cSCC Treatment"}],["$","p",null,{"className":"text-base text-gray-400","children":"10"}]]}]]}]}],null],null],null]},[null,["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children","10","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[null,["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children","pages","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined"}]],null]},[[[["$","link","0",{"rel":"stylesheet","href":"/_next/static/css/8d323862949ffad9.css","precedence":"next","crossOrigin":"$undefined"}]],["$","html",null,{"lang":"en","className":"dark","children":["$","body",null,{"className":"__className_f367f3 h-1080px w-1920px","children":[["$","$4",null,{"fallback":null,"children":[["$","$L5",null,{}],["$","$L6",null,{}]]}],["$","$L2",null,{"parallelRouterKey":"children","segmentPath":["children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L3",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":[["$","title",null,{"children":"404: This page could not be found."}],["$","div",null,{"style":{"fontFamily":"system-ui,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif,\"Apple Color Emoji\",\"Segoe UI Emoji\"","height":"100vh","textAlign":"center","display":"flex","flexDirection":"column","alignItems":"center","justifyContent":"center"},"children":["$","div",null,{"children":[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}"}}],["$","h1",null,{"className":"next-error-h1","style":{"display":"inline-block","margin":"0 20px 0 0","padding":"0 23px 0 0","fontSize":24,"fontWeight":500,"verticalAlign":"top","lineHeight":"49px"},"children":"404"}],["$","div",null,{"style":{"display":"inline-block"},"children":["$","h2",null,{"style":{"fontSize":14,"fontWeight":400,"lineHeight":"49px","margin":0},"children":"This page could not be found."}]}]]}]}]],"notFoundStyles":[]}]]}]}]],null],null],["$L7",null]]]]
7:[["$","meta","0",{"name":"viewport","content":"width=device-width, initial-scale=1"}],["$","meta","1",{"charSet":"utf-8"}],["$","title","2",{"children":"Unloxcyt Market Survey - Interactive Presentation"}],["$","meta","3",{"name":"description","content":"Comprehensive market analysis of Cosibelimab-ipdl for advanced cSCC"}],["$","meta","4",{"name":"next-size-adjust"}]]
1:null
